Anti-vascular endothelial growth factor (anti-VEGF): its function in proliferative diabetic retinopathy management

作者
Cristina Scerbatiuc
标识
DOI:10.52645/mjhs.2024.2.08
摘要

Introduction. Among working-age adults, diabetes is a primary cause of visual impairment. Pan-retinal photocoagulation, the standard treatment for proliferative diabetic retinopathy, is effective but comes with well-established adverse effects, including limitations on the peripheral visual field. The mechanism of vascular proliferation is thought to be triggered by vascular endothelial growth factor (anti-VEGF). Anti-VEGF medications have been studied extensively in the treatment of diabetic macular edema, and the results suggest that treatment with anti-VEGF medications causes a decrease in diabetic retinopathy. Anti-VEGF therapies can be used to treat underlying proliferative diabetic retinopathy in cases of vitreous bleeding when platelet-rich plasma cannot be used, delaying, or reducing the necessity for a vitrectomy. However, the limitations of anti-VEGF therapy require careful patient selection and constant observation. Recent clinical trials and recommendations for the use of anti-VEGF in proliferative diabetic retinopathy are presented in this review. Material and methods. The effectiveness of anti-VEGF medicines in the treatment of diabetic retinopathy was the subject of a comprehensive review of the scientific and medical literature. A structured search was performed in the PubMed, Scopus, and HINARI databases, considering relevant articles published in the last 10 years. The search terms used (in English) were: “angiogenesis inhibitors”, “anti-VEGF”, “pan-retinal photocoagulation”, “intravitreal injection”, “diabetic retinopathy”. Accurate diagnosis, side effects, quality of life, and patient satisfaction were analyzed and compared for each treatment option. Results. Anti-VEGF treatments have been demonstrated to be beneficial in reducing macular edema, enhancing visual acuity, and slowing the advancement of diabetic retinopathy. While generally safe, different anti-VEGF medicines have varied side effects profiles. Conclusion. When choosing an anti-VEGF treatment for diabetic retinopathy, factors such as patient satisfaction, quality of life, side effects, and correct diagnosis should be taken into account. While anti-VEGF treatments show promise, further study is required to fully understand their advantages and disadvantages and to optimize their application.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
GIN的应助被sinalpha10采纳,获得10
刚刚
1秒前
GIN的应助被sinalpha10采纳,获得10
1秒前
molihuakai的应助被老赵采纳,获得10
1秒前
1秒前
bfs发布了新的文献求助10
1秒前
司徒呀完成签到,获得积分10
2秒前
失眠孤兰发布了新的文献求助10
2秒前
Liv关闭了Liv的文献求助
3秒前
梨花飘落在你窗前完成签到,获得积分10
3秒前
予秋发布了新的文献求助10
3秒前
小马甲的应助被忧郁的钥匙采纳,获得10
4秒前
4秒前
4秒前
雾里青发布了新的文献求助10
4秒前
Mars完成签到 ,获得积分10
4秒前
贾贾闇完成签到,获得积分10
5秒前
5秒前
成长中完成签到,获得积分10
5秒前
6秒前
6秒前
Nole的应助被gq100520采纳,获得10
6秒前
00hello00发布了新的文献求助10
6秒前
大个的应助被不敢说话采纳,获得10
7秒前
7秒前
7秒前
7秒前
飘逸的苡完成签到,获得积分10
8秒前
勤劳茗完成签到,获得积分10
9秒前
9秒前
pengxueguo完成签到,获得积分20
9秒前
积极鱼发布了新的文献求助10
9秒前
10秒前
耶耶业发布了新的文献求助10
10秒前
Mrzhao发布了新的文献求助10
10秒前
ws完成签到,获得积分10
11秒前
11秒前
12秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193425
求助须知:如何正确求助?哪些是违规求助? 9579620
关于积分的说明 21866505
捐赠科研通 7793025
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560718
邀请新用户注册赠送积分活动 2484128